Activation and Antagonism of the OAS–RNase L Pathway

The oligoadenylate synthetase–ribonuclease L (OAS–RNase L) system is a potent antiviral pathway that severely limits the pathogenesis of many viruses. Upon sensing dsRNA, OASs produce 2′,5′-oligoadenylates (2-5A) that activate RNase L to cleave both host and viral single-stranded RNA, thereby limiti...

Full description

Bibliographic Details
Main Author: Susan R. Weiss
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Proceedings
Subjects:
Online Access:https://www.mdpi.com/2504-3900/50/1/14
id doaj-872da033e61548679b09590c8a8ce53d
record_format Article
spelling doaj-872da033e61548679b09590c8a8ce53d2020-11-25T02:49:58ZengMDPI AGProceedings2504-39002020-06-0150141410.3390/proceedings2020050014Activation and Antagonism of the OAS–RNase L PathwaySusan R. Weiss0Department of Microbiology, Perelman School of Medicine. University of Pennsylvania, Philadelphia, PA 19104, USAThe oligoadenylate synthetase–ribonuclease L (OAS–RNase L) system is a potent antiviral pathway that severely limits the pathogenesis of many viruses. Upon sensing dsRNA, OASs produce 2′,5′-oligoadenylates (2-5A) that activate RNase L to cleave both host and viral single-stranded RNA, thereby limiting protein production, virus replication and spread, leading to apoptotic cell death. Endogenous host dsRNA, which accumulates in the absence of adenosine deaminase acting on RNA (ADAR)1, can also activate RNase L and lead to apoptotic cell death. RNase L activation and antiviral activity during infections with several types of viruses in human and bat cells is dependent on OAS3 but independent of virus-induced interferon (IFN) and, thus, RNase L can be activated even in the presence of IFN antagonists. Differently from other human viruses examined, Zika virus is resistant to the antiviral activity of RNase L and instead utilizes RNase L to enhance its replication factories to produce more infectious virus. Some betacoronaviruses antagonize RNase L activation by expressing 2′,5′-phosphodiesterases (PDEs) that cleave 2-5A and thereby antagonize activation of RNase L. The best characterized of these PDEs is the murine coronavirus (MHV) NS2 accessory protein. Enzymatically active NS2 is required for replication in myeloid cells and in the liver. Interestingly, while wild type mice clear MHV from the liver by 7–10 days post-infection, RNase L knockout mice fail to effectively clear MHV, probably due to diminished apoptotic death of infected cells. We suggest that RNase L antiviral activity stems from direct cleavage of viral genomes and cessation of protein synthesis as well as through promoting death of infected cells, limiting the spread of virus. Importantly, OASs are pattern recognition receptors and the OAS–RNase L pathway is a primary innate response pathway to viruses, capable of early response, coming into play before IFN is induced or when the virus shuts down IFN signaling.https://www.mdpi.com/2504-3900/50/1/14murine coronavirusoligoadenylate-ribonuclease Linterferon antagonistphosphodiesteraseOAS3ADAR1
collection DOAJ
language English
format Article
sources DOAJ
author Susan R. Weiss
spellingShingle Susan R. Weiss
Activation and Antagonism of the OAS–RNase L Pathway
Proceedings
murine coronavirus
oligoadenylate-ribonuclease L
interferon antagonist
phosphodiesterase
OAS3
ADAR1
author_facet Susan R. Weiss
author_sort Susan R. Weiss
title Activation and Antagonism of the OAS–RNase L Pathway
title_short Activation and Antagonism of the OAS–RNase L Pathway
title_full Activation and Antagonism of the OAS–RNase L Pathway
title_fullStr Activation and Antagonism of the OAS–RNase L Pathway
title_full_unstemmed Activation and Antagonism of the OAS–RNase L Pathway
title_sort activation and antagonism of the oas–rnase l pathway
publisher MDPI AG
series Proceedings
issn 2504-3900
publishDate 2020-06-01
description The oligoadenylate synthetase–ribonuclease L (OAS–RNase L) system is a potent antiviral pathway that severely limits the pathogenesis of many viruses. Upon sensing dsRNA, OASs produce 2′,5′-oligoadenylates (2-5A) that activate RNase L to cleave both host and viral single-stranded RNA, thereby limiting protein production, virus replication and spread, leading to apoptotic cell death. Endogenous host dsRNA, which accumulates in the absence of adenosine deaminase acting on RNA (ADAR)1, can also activate RNase L and lead to apoptotic cell death. RNase L activation and antiviral activity during infections with several types of viruses in human and bat cells is dependent on OAS3 but independent of virus-induced interferon (IFN) and, thus, RNase L can be activated even in the presence of IFN antagonists. Differently from other human viruses examined, Zika virus is resistant to the antiviral activity of RNase L and instead utilizes RNase L to enhance its replication factories to produce more infectious virus. Some betacoronaviruses antagonize RNase L activation by expressing 2′,5′-phosphodiesterases (PDEs) that cleave 2-5A and thereby antagonize activation of RNase L. The best characterized of these PDEs is the murine coronavirus (MHV) NS2 accessory protein. Enzymatically active NS2 is required for replication in myeloid cells and in the liver. Interestingly, while wild type mice clear MHV from the liver by 7–10 days post-infection, RNase L knockout mice fail to effectively clear MHV, probably due to diminished apoptotic death of infected cells. We suggest that RNase L antiviral activity stems from direct cleavage of viral genomes and cessation of protein synthesis as well as through promoting death of infected cells, limiting the spread of virus. Importantly, OASs are pattern recognition receptors and the OAS–RNase L pathway is a primary innate response pathway to viruses, capable of early response, coming into play before IFN is induced or when the virus shuts down IFN signaling.
topic murine coronavirus
oligoadenylate-ribonuclease L
interferon antagonist
phosphodiesterase
OAS3
ADAR1
url https://www.mdpi.com/2504-3900/50/1/14
work_keys_str_mv AT susanrweiss activationandantagonismoftheoasrnaselpathway
_version_ 1724741025898954752